GEIST:UPC Searchengine

UPC_CFI_230/2023

DexCom, Inc. v. Abbott Scandinavia Aktiebolag, Abbott NV / SA, Abbott S.r.l., Abbott Diabetes Care Inc., Abbott Diagnostics GmbH, Abbott France, Abbott B.V., Abbott Logistics B.V., Abbott GmbH, Abbott Laboratories

Datum
2024-07-04
Kammer
Paris (FR) Local Division
Verfahrensart
Generic Order
Sprache
EN

Metadaten

Fall-IDUPC_CFI_230-2023-09fdd22d35fd
Aktenzeichen
RegisterzeichenUPC_CFI_230/2023
EntscheidungsreferenzORD_37297/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 28

1 Paris Local Division Decision in an action for infringement with counterclaim for revocation UPC_CFI_230/2023 Decision on the merits of the Court of First Instance of the Unified Patent Court delivered on 04/07/2024 concerning EP3435866 HEADNOTES The scope of the dispute brought before the Court is incontestably governed by the principle that the parties define the subject-matter of the dispute, a general principle of law which is reiterated in Art. 76(1) of the UPC Agreement and which, moreover, allows the claimant in the main action to exclude certain acts of infringement in order to avoid the inconvenience of parallel jurisdictions between the UPC and national courts during the transitional period provided for in Art. 83 of the Agreement ("carve out"). However, this principle cannot r ...